Stanley Lapidus - Net Worth and Insider Trading

Stanley Lapidus Net Worth

The estimated net worth of Stanley Lapidus is at least $107,984 dollars as of 2024-11-13. Stanley Lapidus is the Director of Lucid Diagnostics Inc and owns about 101,592 shares of Lucid Diagnostics Inc (LUCD) stock worth over $107,688. Stanley Lapidus is also the Director of T2 Biosystems Inc and owns about 530 shares of T2 Biosystems Inc (TTOO) stock worth over $296. Details can be seen in Stanley Lapidus's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stanley Lapidus has not made any transactions after 2023-09-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Stanley Lapidus

To

Stanley Lapidus Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stanley Lapidus owns 2 companies in total, including T2 Biosystems Inc (TTOO) , and Lucid Diagnostics Inc (LUCD) .

Click here to see the complete history of Stanley Lapidus’s form 4 insider trades.

Insider Ownership Summary of Stanley Lapidus

Ticker Comapny Transaction Date Type of Owner
TTOO T2 Biosystems Inc 2019-06-11 director
LUCD Lucid Diagnostics Inc 2023-09-26 director

Stanley Lapidus Latest Holdings Summary

Stanley Lapidus currently owns a total of 2 stocks. Among these stocks, Stanley Lapidus owns 101,592 shares of Lucid Diagnostics Inc (LUCD) as of September 26, 2023, with a value of $107,688 and a weighting of 99.73%. Stanley Lapidus also owns 530 shares of T2 Biosystems Inc (TTOO) as of June 11, 2019, with a value of $296 and a weighting of 0.27%.

Latest Holdings of Stanley Lapidus

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LUCD Lucid Diagnostics Inc 2023-09-26 101,592 1.06 107,688
TTOO T2 Biosystems Inc 2019-06-11 530 0.56 296

Holding Weightings of Stanley Lapidus


Stanley Lapidus Form 4 Trading Tracker

According to the SEC Form 4 filings, Stanley Lapidus has made a total of 4 transactions in Lucid Diagnostics Inc (LUCD) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Lucid Diagnostics Inc is the sale of 29,947 shares on September 26, 2023, which brought Stanley Lapidus around $43,423.

According to the SEC Form 4 filings, Stanley Lapidus has made a total of 0 transactions in T2 Biosystems Inc (TTOO) over the past 5 years. The most-recent trade in T2 Biosystems Inc is the sale of 90 shares on June 11, 2019, which brought Stanley Lapidus around $12,960.

Insider Trading History of Stanley Lapidus

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stanley Lapidus Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stanley Lapidus Ownership Network

Ownership Network List of Stanley Lapidus

No Data

Ownership Network Relation of Stanley Lapidus

Insider Network Chart

Stanley Lapidus Owned Company Details

What does T2 Biosystems Inc do?

Who are the key executives at T2 Biosystems Inc?

Stanley Lapidus is the director of T2 Biosystems Inc. Other key executives at T2 Biosystems Inc include 10 percent owner Cr Group L.p. , 10 percent owner Crg Partners Iii (cayman) Unlev Aiv I L.p. , and 10 percent owner Crg Partners Iii (cayman) Lev Aiv I L.p. .

T2 Biosystems Inc (TTOO) Insider Trades Summary

Over the past 18 months, Stanley Lapidus made no insider transaction in T2 Biosystems Inc (TTOO). Other recent insider transactions involving T2 Biosystems Inc (TTOO) include a net sale of 48,345,798 shares made by Cr Group L.p. , and a net sale of 55 shares made by David B Elsbree .

In summary, during the past 3 months, insiders sold 55 shares of T2 Biosystems Inc (TTOO) in total and bought 0 shares, with a net sale of 55 shares. During the past 18 months, 483,513 shares of T2 Biosystems Inc (TTOO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 483,513 shares.

T2 Biosystems Inc (TTOO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

T2 Biosystems Inc Insider Transactions

No Available Data

Stanley Lapidus Mailing Address

Above is the net worth, insider trading, and ownership report for Stanley Lapidus. You might contact Stanley Lapidus via mailing address: 101 Hartwell Ave., Lexington Ma 02421.